FIELD: medicine, oncology.
SUBSTANCE: the present innovation deals with treating patients with generalized skin melanoma at single and multiple cerebral metastases and extracerebral lesions. The method includes systemic immunochemotherapy. For this purpose, on removing a single cerebral metastasis and melanomatous focus or at multiple cerebral lesions when operation is contraindicated it is necessary to carry out a 2-wk-long course of autohemoimmunochemotherapy, that is: 400 ml patient's autoblood should be sampled into a vial with hemoconservant and after sedimentation it should be divided into 2 equal fractions - plasma and autologous cell suspension (ACS). In separate vials it is necessary to prepare 3 media - 200 ml autoplasma (medium N1) and per 100 ml ACS (medium N2 and N3). One should incubate for 1 h in thermostat at 37° C medium N1 with 100 mg carmustine (mixture N1), medium N2 - with 25 mg metothrexate and 1 mg vincristine (mixture N2), medium N3 - with Reaferon at the dosage of 5×106 IU Reaferon (mixture N3). On the 1st d of the course one should inject mixtures intravenously by drops successively every mixture per 60 min, mixture N2 should be injected repeatedly on the 8th d of the course, mixture N3 should be injected by drops along paracetamol intake thrice weekly during the whole 2-wk-long course of therapy. Additionally, one should fulfill intravenous infusions of 150 mg carboplatin and 15 mg bleomycin upon 200 ml autoblood by drops on the 2nd and 4th d of the course, correspondingly. Totally, one should carry out 3-6 courses. The innovation provides stable regression of neurological symptoms due to decreasing the volume of cerebral metastasis and reactive perifocal cerebral edema and increasing relapse-free and metastasis-free periods and, also, life period in patients.
EFFECT: higher efficiency of therapy.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING ONCOLOGICAL PATIENTS WITH METASTATIC CEREBRAL LESION | 2005 |
|
RU2290974C1 |
METHOD FOR TREATING GENERALIZED SKIN MELANOMA | 2005 |
|
RU2301061C2 |
METHOD FOR PREDICTING EXTRACRANIAL METASTASES DEVELOPMENT IN PATIENTS HAVING METASTASES IN BRAIN | 2005 |
|
RU2297005C1 |
METHOD FOR PREDICTING BRAIN METASTATIC INJURIES GENERALIZATION | 2005 |
|
RU2300104C2 |
METHOD OF NON-HODGKIN'S LYMPHOMAS TREATMENT | 2000 |
|
RU2180594C1 |
METHOD FOR DETECTING EXTRACRANIAL METASTASES IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300110C2 |
METHOD FOR PREDICTING CEREBRAL METASTASIS LESION FOCI IN METASTATIC BRAIN INJURY PATIENTS | 2005 |
|
RU2300109C2 |
METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
BREAST CANCER CHEMOTHERAPY PROCEDURE | 2008 |
|
RU2372917C1 |
THERAPY OF BONE METASTASES IN BREAST CANCER | 2007 |
|
RU2360682C1 |
Authors
Dates
2006-10-27—Published
2005-04-12—Filed